CytoDyn to host investor webcast on corporate and clinical progress
CYDY•CytoDyn will host an investor webcast on October 19, 2026, at 1 p.m. PT, covering financial progress, 2026 priorities and upcoming milestones. Natera’s Reny Aniline will discuss the companies’ collaboration and early ctDNA observations from the CLOVER study.
1. Webcast agenda
CytoDyn said it will provide corporate and clinical updates during the webcast, including financial progress, 2026 priorities and upcoming milestones. Natera’s Reny Aniline will discuss the strategic collaboration and early ctDNA observations from the CLOVER study.
